Business · 10/16/2026
Fit-for-Purpose Rare Disease Framework Initiative; Public Meeting; Request for Information and Comments
The Food and Drug Administration (FDA) is announcing a public meeting entitled 'Fit-for-Purpose Rare Disease Framework Initiative' to be convened by the Reagan-Udall Foundation.
Original source language: Federal Register — Health and Human ServicesOpen original release →